MEDNET 2007 - 12th World Congress on Internet in Medicine

MEDNET is a scientific conference organized under the auspices of the Society for the Internet in Medicine (SIM). MEDNET 2007 will be hosted by the Center for Healthcare Management at Germany's No. 1 listed Business School Leipzig Graduate School of Management (HHL).

The official journal is the Journal of Medical Internet Research (JMIR), the leading Open Acesss eHealth journal - www.jmir.org.

Besides the focus points "Economics of Internet & Medicine Applications" and "EHR and the electronic Health Card" MEDNET 2007 will have - as every year - many topics around Internet & Medicine.

MEDNET 2007 Tracks and Themes:

  • Putting electronic health records online
  • Open Source Initiatives in Internet & Healthcare
  • Integrated care & Workflow Management over the Internet
  • Patient Education and Information
  • Etrials: using the web and etechnologies for clinical trials
  • Public (e-)health, population health technologies, surveillance
  • Telemedicice and Heart Failure Management
  • Internet-based Management of Pace-Makers
  • Legal aspects of Internet and Medicine
  • Web-based medical education
  • Health communication on the internet
  • Online pharmacies
  • Internet publishing in medicine
  • Other topics

For further information, please visit:
www.mednet2007.com

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...